Meta-Analysis of Randomized Trials of Angioedema as an Adverse Event of Renin–Angiotensin System Inhibitors

This publication has 56 references indexed in Scilit:

• Safety and Tolerability of the Direct Renin Inhibitor Aliskiren: A Pooled Analysis of Clinical Experience in More Than 12,000 Patients With Hypertension
  The Journal of Clinical Hypertension, 2010
• Effects of candesartan cilexetil on carotid remodeling in hypertensive diabetic patients: the MITEC study
  Vascular Health and Risk Management, 2009
• Angiotensin-Converting Enzyme Inhibitors and Angioedema
  Hypertension, 2008
• Nonallergic angioedema: role of bradykinin
  Allergy, 2007
• Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin‐converting enzyme treatment. Relationships with endothelial function, coagulation and inflammation
  British Journal of Haematology, 2005
• Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery Disease
  New England Journal of Medicine, 2004
• Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study)
  BMJ, 2004
• Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
  JAMA, 2002
• Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
  The Lancet, 1997
• Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD)
  American Heart Journal, 1996